Skip to main
BIOX
BIOX logo

BIOX Stock Forecast & Price Target

BIOX Analyst Ratings

Based on 3 analyst ratings
Buy
Strong Buy 33%
Buy 33%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

Bioceres Crop Solutions Corp has demonstrated resilience in its Crop Protection portfolio, with notable strength observed outside of Argentina, which positions the company favorably for potential recoveries in the local market. The firm is also focusing on international opportunities for its HB4 wheat product, anticipating significant revenue growth from markets in the US, Brazil, and Australia, despite the gradual ramp-up of revenue as partnerships are established. Additionally, the overall performance has been supplemented by robust sales in bio-protection products in the US and Latin America, as well as increased adjuvant sales in Brazil, mitigating weaker results from the Argentine market.

Bears say

Bioceres Crop Solutions has experienced significant revenue declines, particularly in its Crop Protection and Crop Nutrition segments, driven by weaker demand in Argentina and reduced contributions from HB4-related sales. Specifically, the Crop Nutrition segment saw a year-over-year decrease of approximately 34%, attributed to softer market demand and pricing pressures in Argentina's fertilizer markets, further impacted by lower corn acreage. Additionally, the company's transition to a licensing-based business model led to a dramatic 75% year-over-year drop in Seed & Integrated products revenue, reflecting the challenges associated with exiting its traditional seed production and sales operations.

BIOX has been analyzed by 3 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 33% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Bioceres Crop Solutions Corp and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Bioceres Crop Solutions Corp (BIOX) Forecast

Analysts have given BIOX a Buy based on their latest research and market trends.

According to 3 analysts, BIOX has a Buy consensus rating as of Dec 16, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $4.42, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $4.42, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Bioceres Crop Solutions Corp (BIOX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.